Accelerating Precision Medicine by Pairing NGS Kits with Ready-to-Use Analysis Workflows
In the realm of DNA sequencing, technology developers contribute to advancement in important ways, by building increasingly fast-moving tools that untangle the intricacies of the human genome, and by constructing analytics platforms to wade through the resulting mountains of genetic data.
Recently, DNAnexus and Twist Bioscience announced a collaboration aimed at accelerating research and reducing the time to design, validate, and commercialize new, high-quality, next-generation sequencing (NGS)-based diagnostic tests.
In this webinar we will cover the challenges that this collaboration aims to solve and how the partnership is poised to enable significant scientific outcomes. We will also take your questions live about this exciting advancement. Topics include:
How the healthcare and life sciences industry can leverage biomedical data to accelerate scientific discoveries and deliver better patient care
The importance of achieving superior NGS target enrichment efficiency
Why reducing complex data analysis bottlenecks helps simplify operations and accelerates time-to-insight
The impact that leveraging a purpose-built bioinformatics platform offers in terms of resources, cost savings, and risk avoidance
Esteban is Sr. Director of R&D at Twist Bioscience, focusing on product development for the synthetic biology and genomics fields. He has held various positions at Twist spanning molecular biology, bioinformatics, and data science. His career has focused on combining wet- and dry-lab science, with an emphasis on NGS technologies and DNA and RNA biology. Prior to Twist, Esteban was Head of Data at Upside Foods. He holds a Ph.D. in developmental biology from Stanford University.
Ray Moran is an experienced Leader in Bioinformatics, Data Science and Pre-sales engineering. He enjoys working leading a team in a commercial setting alongside customers to identify pain points and solve them using practical but efficient solutions in the bioinformatics space. Leveraging experience from an accredited Laboratory environment to early stage startup, the array of experiences allows him to have a unique understanding of a broad range of use cases.
